All In MedTech

Device Trial Radar · NCT07017998

External Therapy for Tinnitus Management

Mild Therapeutic Hypothermia for Tinnitus Management

Last checked: Nov 19, 2026Latest source record: Jul 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Jul 16, 2025

Primary completion

Jun 30, 2027

Study completion Dec 1, 2027

Sponsor

Lead sponsor
Restorear Devices LLCNot on our public-company list
Sponsor type
Industry
First posted
Jun 12, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this remote interventional clinical study is to investigate the use of mild therapeutic hypothermia devices for the symptomatic relief of chronic tinnitus. The main aims of the study are: 1. Ascertain the effects of MTH in chronic tinnitus patients using questionnaires measuring tinnitus severity and intervention-related change. 2. Ascertain the comfort and acceptability of the hypothermia device and therapy. Participants with chronic tinnitus will wear the mild therapeutic hypothermia therapy devices for a single 30 minute session. Researchers will compare results from those receiving therapy to those from a control group.

Conditions

  • Tinnitus
  • Tinnitus, Subjective

Interventions

  • Cold pack-delivered mild therapeutic hypothermiaDevice

    Mild therapeutic hypothermia (cooling), delivered non-invasively to the structures of the inner ear (cochlea) for 30 minutes, using headband-style proprietary device, ReBound.

  • Sham (No Treatment)Device

    Sham headband-style device will be worn for 30 minutes. Participants will be told they are receiving therapy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Subjective Tinnitus SeverityTime frame: Immediately prior to and immediately after treatment or sham treatment.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • RestorEar Devices

    Bozeman, Montana · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.